Cost-Effectiveness of Osimertinib in NSCLC: US Analysis
In recent years, the landscape of cancer treatment has been transformed by the advent of targeted therapies, particularly for non-small ...
Tag: third-generation EGFR inhibitors
Overcoming EGFR TKI Resistance in Mutant NSCLC
Resistance to EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant NSCLC: Unraveling the Complex Landscape of Therapeutic Evasion In the relentless battle ...
Double-Dose Furmonertinib: Efficacy in EGFR Ex20ins NSCLC
In the realm of oncology, the landscape of targeted therapies is rapidly evolving. Recent research has illuminated the potential of ...
COMPEL Study Finds Adding Chemotherapy to Osimertinib After Progression Enhances Progression-Free Survival in EGFR-Mutated NSCLC
In a groundbreaking development in the treatment of advanced non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) ...
High-Dose EGFR-TKIs Plus Pemetrexed Combat NSCLC
In the relentless battle against advanced non-small-cell lung cancer (NSCLC) harboring epidermal growth factor receptor mutations (EGFRm), a recent study ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!